← back to search

Richard Graham

California Dental Association Foundation ·
Area of research
Molecular Biology · Experimental and Cognitive Psychology
Research interest
Research interests include Hedgehog Signaling Pathway Studies, Creativity in Education and Neuroscience, Film in Education and Therapy, and Advanced Breast Cancer Therapies.
h-index
36
citations
6,528
works
342
NIH funding
primary concept
email

Recent publications

Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme
Journal of Crohn s and Colitis 2020cited by 84position: middledoi
Evaluation of Food Effect on Pharmacokinetics of Vismodegib in Advanced Solid Tumor Patients
Clinical Cancer Research 2013cited by 35position: middledoi
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
New England Journal of Medicine 2012cited by 1,433position: middledoi
Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects
British Journal of Clinical Pharmacology 2012cited by 59position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2012–2012)Howard Mackey · Gene Therapy Laboratory1 papers (2012–2012)Ezra E.W. Cohen · University of Michigan1 papers (2013–2013) · 1 papers (2012–2012) · 1 papers (2012–2012)Michael R. Migden · The University of Texas MD Anderson Cancer Center1 papers (2012–2012)Mark J. Dresser · Gilead Sciences (United States)1 papers (2012–2012)Karl D. Lewis · Regeneron (United States)1 papers (2012–2012) · 1 papers (2020–2020)David L. Boyle · La Jolla Institute for Immunology1 papers (2020–2020)Reuben Sana · San Francisco VA Medical Center1 papers (2020–2020)James Solomon · University of Illinois Chicago1 papers (2012–2012) · 1 papers (2020–2020)Philip Friedlander · Mount Sinai Medical Center1 papers (2012–2012)Bethany Kell · University of Chicago1 papers (2013–2013)Anthony E. Oro · Stanford Medicine1 papers (2012–2012)Richard L. Schilsky · American Society of Clinical Oncology1 papers (2013–2013)William J. Sandborn · Mirati Therapeutics (United States)1 papers (2020–2020)Michael L. Maitland · Amsterdam University Medical Centers1 papers (2013–2013)Theodore Karrison · NRG Oncology1 papers (2013–2013)